Clinical Trials Logo
  1. Home
  2. Pain and Metabolic Syndrome
  3. NCT00885261
  4. Details
NCT00885261 Clinical Trial

The Prevalence of Metabolic Syndrome in Patients Suffering From Chronic Pain

Pain and Metabolic Syndrome Clinical Trial

Official title:
The Prevalence of Metabolic Syndrome in Patients Suffering From Chronic Pain

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00885261
Other study ID # TASMC-09-SB-096-CTIL
Secondary ID
Status Completed
Phase N/A
First received April 19, 2009
Last updated March 26, 2014
Start date May 2009
Est. completion date April 2012

Study information
Verified date April 2009
Source Tel-Aviv Sourasky Medical Center
Contact n/a
Is FDA regulated No
Health authority Israel: Ethics Commission
Study type Observational

Clinical Trial Summary

Obesity is considered as the epidemic of the century. Central obesity is one of the metabolic syndrome's features. It has been proven that obesity can cause back pain and headaches; thus, there might be a link between chronic pain and the syndrome.

The objective of this study is to assess the prevalence of metabolic syndrome in patients suffering from chronic pain.

Description:

All patients will answer a questionnaire, their hip circumference will be measured, and their BMI will be calculated (weight/(height)2 ).

The patients' blood pressure will be measured. The patients will be asked to bring their blood tests (lipids and glucose).

Recruitment information / eligibility
Status Completed
Enrollment 100
Est. completion date April 2012
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients over 18 that suffer from chronic pain and are being treated at the pain medicine unit

Exclusion Criteria:

- Pregnant women, patients with abdominal wall defects

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
Israel Pain Medicine Unit Tel Aviv

Sponsors (1)
Lead Sponsor Collaborator
Tel-Aviv Sourasky Medical Center

Country where clinical trial is conducted

Israel,